GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $10,775,000 | +119.2% | 158,222 | +31.2% | 0.01% | +150.0% |
Q1 2021 | $4,915,000 | -18.1% | 120,623 | -12.9% | 0.00% | -20.0% |
Q4 2020 | $5,999,000 | -18.6% | 138,517 | +3.7% | 0.01% | -28.6% |
Q3 2020 | $7,367,000 | -10.7% | 133,612 | +2.2% | 0.01% | -12.5% |
Q2 2020 | $8,251,000 | +25.1% | 130,706 | +1.3% | 0.01% | 0.0% |
Q1 2020 | $6,593,000 | -49.7% | 129,052 | -21.8% | 0.01% | -33.3% |
Q4 2019 | $13,118,000 | +136.5% | 165,032 | +44.4% | 0.01% | +100.0% |
Q3 2019 | $5,546,000 | +83.3% | 114,311 | +98.7% | 0.01% | +50.0% |
Q2 2019 | $3,026,000 | +19.4% | 57,524 | +20.2% | 0.00% | +33.3% |
Q1 2019 | $2,534,000 | +27.1% | 47,867 | -1.4% | 0.00% | 0.0% |
Q4 2018 | $1,994,000 | 0.0% | 48,567 | -7.4% | 0.00% | 0.0% |
Q3 2018 | $1,994,000 | -23.5% | 52,467 | -9.0% | 0.00% | -25.0% |
Q2 2018 | $2,606,000 | +598.7% | 57,645 | +646.9% | 0.00% | +300.0% |
Q1 2018 | $373,000 | -7.7% | 7,718 | -24.8% | 0.00% | 0.0% |
Q4 2017 | $404,000 | – | 10,262 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
Grace Capital | 131,549 | $5,697,000 | 3.60% |
Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |